Evotec SE EVO
NASDAQ EVO
$1.56 +0.08 (+5.41%)
At close: Oct 21, 2026 · 4:00 PM EDT

Evotec SE (EVO) Current Deferred Revenue (2009 - 2026)

Updated

Evotec SE's Current Deferred Revenue came in at $79.52 million for the quarter ended Jun 30, 2026, down 47.0% from $150.09 million a year earlier and down 39.2% from the prior quarter.

Analysis

Evotec SE (EVO) Current Deferred Revenue (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Evotec SE's Current Deferred Revenue was $118.46 million, up 2.7% from the prior year.

  • Current Deferred Revenue carries a five-year compound annual growth rate of 9.3% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Current Deferred Revenue was $115.38 million in the year ended Dec 31, 2024 (+9.3%), $105.56 million in the year ended Dec 31, 2023 (-18.5%), $129.55 million in the year ended Dec 31, 2022 (-2.3%) and $132.61 million in the year ended Dec 31, 2021 (+74.7%).
  • The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Current Deferred Revenue since the quarter ended Jun 30, 2022.
  • Year-over-year, Current Deferred Revenue increased in three of the last five quarters, with an average decline of 3.5%.
  • The fastest year-over-year change in Current Deferred Revenue over five years came in the quarter ended Sep 30, 2022 (growth of 86.4%), and the weakest in the quarter ended Jun 30, 2026 (a decline of 47.0%).
  • Business Quant data shows EVO's Current Deferred Revenue at $130.81 million (quarter ended Mar 31, 2026), $122.05 million (quarter ended Dec 31, 2025) and $124.89 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 46.02 Bn 37.72 Bn 1.44 Bn
2 Medpace Holdings 18.62 Bn 16.68 Bn 201.64 Mn
3 Charles River Laboratories International 16.56 Bn 15.75 Bn 363.37 Mn
4 Icon 14.56 Bn 11.67 Bn 479.29 Mn
5 Fortrea Holdings 2.30 Bn 1.68 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 619.39 Mn -142.69 Mn 18.44 Mn
7 Evotec SE 552.27 Mn -1.06 Bn -
8 Champions Oncology 67.82 Mn 42.90 Mn 7.70 Mn
9 MindWalk Holdings 58.45 Mn 22.10 Mn 1.61 Mn
10 Natural Alternatives International 6.99 Mn -21.09 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 78.14 Mn
Mar 31, 2026 128.05 Mn
Dec 31, 2025 123.17 Mn
Sep 30, 2025 125.32 Mn
Jun 30, 2025 155.49 Mn
Mar 31, 2025 136.13 Mn
Dec 31, 2024 110.93 Mn
Sep 30, 2024 110.23 Mn
Dec 31, 2023 108.01 Mn
Jun 30, 2023 150.95 Mn
Dec 31, 2022 131.04 Mn
Sep 30, 2022 130.14 Mn
Jun 30, 2022 -139.95 Mn
Mar 31, 2022 125.98 Mn
Dec 31, 2021 126.91 Mn
Sep 30, 2021 70.44 Mn
Dec 31, 2020 81.77 Mn
Sep 30, 2010 6.57 Mn
Jun 30, 2010 6.06 Mn
Mar 31, 2010 5,988.11
API Access

Evotec SE Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=EVO&period=max&api_key=YOUR_API_KEY